You are here

iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th

NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September 30, 2018 after the close of the market and host a conference call at 4:30pm Eastern Time on Tuesday, November 13th.

Tuesday, November 13th @ 4:30pm Eastern Time 
Domestic:888-599-8686
International:323-994-2093
Conference ID:1529049
Webcast:http://public.viavid.com/index.php?id=131972 
  
Replays available through November 27th
Domestic:844-512-2921
International:412-317-6671
Replay PIN:1529049

In addition, a replay of the call will remain on the Company’s website (www.icadmed.com) until the Company releases its fourth quarter and year ended 2018 financial results. 

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com

or

Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com 

Tuesday, November 6, 2018 - 16:05